Google DeepMind — an artificial intelligence unit owned by Alphabet, Google’s parent company — will be working with Moorfields Eye Hospital NHS Foundation Trust, which is one of the top eye hospitals worldwide.
Together, they’ll research how diabetic retinopathy and age-related macular degeneration cause vision loss and affect more than 100 million people across the globe.
Certain privacy advocates worry that DeepMind will use NHS’ data for non-medical purposes, but DeepMind insists that this is not the case, according to Bloomberg Technology.
More articles on health IT:
CHI St. Luke’s joins Greater Houston HIE
How digital health will drive value through MACRA
Hackers breach Mass General vendor, compromise 4,300 records
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
